A Distinct Immunological Signature in Late‐Onset Myasthenia Gravis: Insights from an Exploratory Proteomics Study

Abstract excerpt

OBJECTIVE: Approximately 80% of patients with myasthenia gravis (MG) have autoantibodies against acetylcholine receptor, and clinical characteristics may vary between early-onset (symptom onset age <50 years) and late-onset MG (EOMG and LOMG), but the pathophysiological differences between EOMG and LOMG are not well established. METHODS: We performed an exploratory in-depth proteomics analysis examining 768...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adrenal Hormones and Disorders
• Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
• Share to Myasthenia Gravis and Thymoma